Poster Abstracts • OFID 2019:6 (Suppl 2) • S831 bacteremia was identified in 22 patients (35.5%) and was significantly more common in group A (60.0% [9/15]) than groups B (43.5% [10/23]) or C (12.5% [3/24]) (P = 0.01). Thirty-day mortality rates were also significantly higher in group A than groups B or C (60.0% [9/15] vs. 13.0% [3/23] and 16.7% [4/24], respectively; P < 0.001) ( Figure  1 ). C. difficile bacteremia (P = 0.16), polymicrobial infection (P = 0.91), and antimicrobial therapy for C. difficile (P = 0.48) were not significantly associated with 30-day mortality. In a multivariate analysis, group A was an independent risk factor for 30-day mortality. (adjusted odds ratio; 7.29 [95% confidence interval; 1.68-31.68], P = 0.01).
